Voyager Therapeutics, Inc.
VYGRNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $105.35M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.89$5.48
- Volume (live)
- -
- Avg. volume (3M)
- 798.27K
Voyager Therapeutics (VYGR) Stock Price & Financial Analysis
Voyager Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.74 - $1.84 |
|---|---|
| 52-Week High | $5.48 |
| 52-Week Low | $1.89 |
| Open | $1.82 |
| Volume (last close) | 1.05M |
| Average Volume (3M) | 798.27K |
| Revenue (TTM) | 34.46M |
|---|---|
| Net Income (TTM) | -107.73M |
| Free Cash Flow (TTM) | -121.42M |
| EPS (TTM) | −$1.81 |
| Profit Margin | -312.63% |
| Operating Margin | -340.08% |
| Return on Equity (ROE) | -69.78% |
| Debt to Equity | 0.21 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 105.35M |
|---|---|
| Shares Outstanding | 60.55M |
| Price to Sales (P/S) | 3.06 |
| Price to Book (P/B) | 0.68 |
| EV/EBITDA | -0.99 |
| 50-Day MA | $2.95 |
|---|---|
| 200-Day MA | $3.55 |
| 1-Year Change | −59.12% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Voyager Therapeutics at a Glance
As of the Oct 23, 2026 close, Voyager Therapeutics (VYGR) has a market capitalization of $105.35M. The stock trades at 3.1× sales. Over the trailing twelve months it lost $107.73M on revenue of $34.46M and burned $121.42M of free cash flow. Revenue fell 19.1% year over year.
As of its latest reported balance sheet, it holds $35.77M in cash and securities against $32.57M of debt, a net cash position of $3.20M.
Voyager Therapeutics does not currently pay a dividend.
The share price is down 59.1% over the past year. At $1.74 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.89 to $5.48, below its 200-day moving average of $3.55.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.75, 690.2% above the Oct 23, 2026 close.
Frequently Asked Questions About Voyager Therapeutics
What is the current stock price for VYGR?
As of the Oct 23, 2026 close, VYGR stock trades at $1.74. The 52-week range is $1.89–$5.48, with a day range of $1.74–$1.84.
What is the P/E ratio for VYGR?
The P/E ratio (Price-to-Earnings) for VYGR is shown in the Key Statistics section. This valuation metric helps compare Voyager Therapeutics, Inc. to industry peers.
Does VYGR pay dividends?
Voyager Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for VYGR?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for VYGR is Buy. The average 12-month price target is $13.75, a 690.2% upside from the Oct 23, 2026 close of $1.74.
What is the market cap of VYGR?
As of the Oct 23, 2026 close, Voyager Therapeutics's market capitalization is $105.4M, classifying it as a micro-cap company. Voyager Therapeutics operates in the Healthcare sector within the Biotechnology industry.